Pyridostigmine and Amifampridine for Myasthenia Gravis

NCT05919407 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Myasthenia Gravis

Interventions

DRUG: Pyridostigmine
DRUG: Amifampridine (base) with modified release
DRUG: Placebo
DRUG: Placebo

Sponsor

Leiden University Medical Center

Collaborators

[object Object]